e-learning
resources
Madrid 2019
Monday, 30.09.2019
Understanding lung disease: novel in vitro models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2019 - A novel ex-vivo approach to study lung injury and repair
S. Kim (London, United Kingdom), R. Mongey (London, United Kingdom), P. Wang (London, United Kingdom), M. Hind (London, United Kingdom), M. Griffiths (London, United Kingdom), C. Dean (London, United Kingdom)
Source:
International Congress 2019 – Understanding lung disease: novel in vitro models
Session:
Understanding lung disease: novel in vitro models
Session type:
Oral Presentation
Number:
1899
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kim (London, United Kingdom), R. Mongey (London, United Kingdom), P. Wang (London, United Kingdom), M. Hind (London, United Kingdom), M. Griffiths (London, United Kingdom), C. Dean (London, United Kingdom). LSC - 2019 - A novel ex-vivo approach to study lung injury and repair. 1899
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
LSC - 2021 - Lung-on-a-chip device for modelling of ventilator induced lung injury
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
LSC - 2021 - Establishment of a human in vitro model for airway epithelial repair and regeneration
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Ex vivo elastase and hydrogen peroxide stimulation in lung slices: novel models to study lung repair
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Development of a porcine model to study donor lung injury
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009
LSC - 2021 - Elastin-like-recombinamer cryogel as a platform for lung regeneration
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
LSC - 2017 - Targeting glucose metabolism in experimental lung injury and fibrosis
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung.
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
LSC - 2021 - Use of differentiated primary human airway epithelial models to study SARS-CoV-2 infection biology and pathogenesis
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021
A novel approach for optimal lung recruitment in acute lung injury
Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury
Year: 2005
LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017
FDG-microPET imaging to comfirm brain death in a mouse model: A useful tool to study related donor lung injury
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Fluorescence bronchoscopy (FB) to detect the early lung cancer developement in high-risk aysmptomatic individuals - a pilot study initial results
Source: Eur Respir J 2001; 18: Suppl. 33, 63s
Year: 2001
LSC - 2019 - Relevant murine model to study the development of COPD pathogenesis in smokers with viral infections
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Methods of identification lung cancer stem cells: a pilot study.
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Ex vivo lung repair: rebuilding a new lung
Source: Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist
Year: 2013
LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept